Stockreport

Corvus Pharmaceuticals rises 5%, prices $175M stock offering at $22.15 [Seeking Alpha]

Corvus Pharmaceuticals, Inc.  (CRVS) 
Last corvus pharmaceuticals, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corvuspharma.com
PDF Sign Up Clinical-stage biopharmaceutical company Corvus Pharmaceuticals ( CRVS priced an upsized underwritten public offering of .9M shares at $22.15 per share. Gro [Read more]